bavituximab Articles
GlobalData Expert Insight: Fall from grace of Peregrine Pharma
17 October 2012
Peregrine Pharma plummets after revealing "discrepancies" in one bavituximab trial
25 September 2012
Showing 1-4 of 4 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
